Top

Published in:

01-08-2018 | Riley Symposium

Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC)

Authors: Ying Liu, Hanying Chen, Weinian Shou

Published in: Pediatric Cardiology | Issue 6/2018

Abstract

Ventricular trabeculation and compaction are two essential morphogenetic events for generating a functionally competent ventricular wall. A significant reduction in trabeculation is usually associated with hypoplastic wall and ventricular compact zone deficiencies, which commonly leads to embryonic heart failure and early embryonic lethality. In contrast, the arrest of ventricular wall compaction (noncompaction) is believed to be causative to the left ventricular noncompaction (LVNC), a genetically heterogeneous disorder and the third most common cardiomyopathy among pediatric patients. After critically reviewing recent findings from genetically engineered mouse models, we suggest a model which proposes that defects in myofibrillogenesis and polarization in trabecular cardiomyocytes underly the common pathogenic mechanism for ventricular noncompaction.

Towbin JA (2010) Left ventricular noncompaction: a new form of heart failure. Heart Fail Clin 6:453–469CrossRefPubMed

Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86:666–671CrossRefPubMedPubMedCentral

Oechslin E, Jenni R (2011) Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity? Eur Heart J 32:1446–1456CrossRefPubMed

Freedom RM, Yoo SJ, Perrin D, Taylor G, Petersen S, Anderson RH (2005) The morphological spectrum of ventricular noncompaction. Cardiology Young 15:345–364CrossRef

Grant RT (1926) An unusual anomaly of the coronary vessels in the malformed heart of a child. Heart 13:273–283

Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, Chung WK, Jefferies JL, Rossano JW, Castleberry CD, Addonizio LJ, Lal AK, Lamour JM, Miller EM, Thrush PT, Czachor JD, Razoky H, Hill A, Lipshultz SE (2017) Pediatric cardiomyopathies. Circ Res 121:855–873CrossRefPubMedPubMedCentral

Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG (2006) Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 114:2671–2678CrossRefPubMed

Nugent AW, Daubeney PE, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG (2005) Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 112:1332–1338CrossRefPubMed

Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG (2003) The epidemiology of childhood cardiomyopathy in Australia. New Engl J Med 348:1639–1646CrossRefPubMed

10.

Towbin JA, Jefferies JL (2017) Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism. Circ Res 121:838–854CrossRefPubMed

11.

Bartman T, Hove J (2005) Mechanics and function in heart morphogenesis. Dev Dyn 233:373–381CrossRefPubMed

12.

Taber LA (1998) Mechanical aspects of cardiac development. Prog Biophys Mol Biol 69:237–255CrossRefPubMed

13.

Moorman AF, Christoffels VM, Anderson RH, van den Hoff MJ (2007) The heart-forming fields: one or multiple? Philos Trans R Soc Lond B 362:1257–1265CrossRef

14.

Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH (2000) Developmental patterning of the myocardium. Anat Rec 258:319–337CrossRefPubMed

15.

Brutsaert DL, Andries LJ (1992) The endocardial endothelium. Am J Physiol 263:H985–H1002PubMed

16.

Risebro CA, Riley PR (2006) Formation of the ventricles. Sci World J 6:1862–1880CrossRef

17.

Taber LA (1998) Mechanical aspects of cardiac development. Progress Biophys Mol Biol 69:237–255CrossRef

18.

Dorri F, Niederer PF, Redmann K, Lunkenheimer PP, Cryer CW, Anderson RH (2007) An analysis of the spatial arrangement of the myocardial aggregates making up the wall of the left ventricle. Eur J Cardiothorac Surg 31:430–437CrossRefPubMed

19.

Lunkenheimer PP, Redmann K, Kling N, Jiang X, Rothaus K, Cryer CW, Wubbeling F, Niederer P, Heitz PU, Ho SY, Anderson RH (2006) Three-dimensional architecture of the left ventricular myocardium. Anat Rec 288:565–578CrossRef

20.

Anderson RH, Ho SY, Sanchez-Quintana D, Redmann K, Lunkenheimer PP (2006) Heuristic problems in defining the three-dimensional arrangement of the ventricular myocytes. Anat Rec A 288:579–586CrossRef

21.

Lunkenheimer PP, Redmann K, Westermann P, Rothaus K, Cryer CW, Niederer P, Anderson RH (2006) The myocardium and its fibrous matrix working in concert as a spatially netted mesh: a critical review of the purported tertiary structure of the ventricular mass. Eur J Cardiothorac Surg 29(Suppl 1):S41–S49CrossRefPubMed

22.

Schmid P, Lunkenheimer PP, Redmann K, Rothaus K, Jiang X, Cryer CW, Jaermann T, Niederer P, Boesiger P, Anderson RH (2007) Statistical analysis of the angle of intrusion of porcine ventricular myocytes from epicardium to endocardium using diffusion tensor magnetic resonance imaging. Anat Rec (Hoboken) 290:1413–1423CrossRef

23.

Anderson RH, Sanchez-Quintana D, Redmann K, Lunkenheimer PP (2007) How are the myocytes aggregated so as to make up the ventricular mass? Semin Thorac Cardiovasc Surg 10:76–86CrossRef

24.

Anderson RH, Sanchez-Quintana D, Niederer P, Lunkenheimer PP (2008) Structural-functional correlates of the 3-dimensional arrangement of the myocytes making up the ventricular walls. J Thorac Cardiovasc Surg 136:10–18CrossRefPubMed

25.

Torrent-Guasp F, Kocica MJ, Corno AF, Komeda M, Carreras-Costa F, Flotats A, Cosin-Aguillar J, Wen H (2005) Towards new understanding of the heart structure and function. Eur J Cardiothorac Surg 27:191–201CrossRefPubMed

26.

Xu Y, Malhotra A, Ren M, Schlame M (2006) The enzymatic function of tafazzin. J Biol Chem 281:39217–39224CrossRefPubMed

27.

Xu Y, Condell M, Plesken H, Edelman-Novemsky I, Ma J, Ren M, Schlame M (2006) A Drosophila model of Barth syndrome. Proc Natl Acad Sci USA 103:11584–11588CrossRefPubMed

28.

Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, Greutmann M, Hurlimann D, Yegitbasi M, Pons L, Gramlich M, Drenckhahn JD, Heuser A, Berger F, Jenni R, Thierfelder L (2008) Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 117:2893–2901CrossRefPubMed

29.

Xing Y, Ichida F, Matsuoka T, Isobe T, Ikemoto Y, Higaki T, Tsuji T, Haneda N, Kuwabara A, Chen R, Futatani T, Tsubata S, Watanabe S, Watanabe K, Hirono K, Uese K, Miyawaki T, Bowles KR, Bowles NE, Towbin JA (2006) Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol Genet Metab 88:71–77CrossRefPubMed

30.

Schweizer PA, Schroter J, Greiner S, Haas J, Yampolsky P, Mereles D, Buss SJ, Seyler C, Bruehl C, Draguhn A, Koenen M, Meder B, Katus HA, Thomas D (2014) The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. J Am Coll Cardiol 64:757–767CrossRefPubMed

31.

Milano A, Vermeer AM, Lodder EM, Barc J, Verkerk AO, Postma AV, van der Bilt IA, Baars MJ, van Haelst PL, Caliskan K, Hoedemaekers YM, Le Scouarnec S, Redon R, Pinto YM, Christiaans I, Wilde AA, Bezzina CR (2014) HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. J Am Coll Cardiol 64:745–756CrossRefPubMed

32.

Probst S, Oechslin E, Schuler P, Greutmann M, Boye P, Knirsch W, Berger F, Thierfelder L, Jenni R, Klaassen S (2011) Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet 4:367–374CrossRefPubMed

33.

Phoon CK, Acehan D, Schlame M, Stokes DL, Edelman-Novemsky I, Yu D, Xu Y, Viswanathan N, Ren M (2012) Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction. J Am Heart Assoc 1:e000455CrossRef

34.

Luxan G, Casanova JC, Martinez-Poveda B, Prados B, D’Amato G, MacGrogan D, Gonzalez-Rajal A, Dobarro D, Torroja C, Martinez F, Izquierdo-Garcia JL, Fernandez-Friera L, Sabater-Molina M, Kong YY, Pizarro G, Ibanez B, Medrano C, Garcia-Pavia P, Gimeno JR, Monserrat L, Jimenez-Borreguero LJ, de la Pompa JL (2013) Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med 19:193–201CrossRefPubMed

35.

Luedde M, Ehlermann P, Weichenhan D, Will R, Zeller R, Rupp S, Muller A, Steen H, Ivandic BT, Ulmer HE, Kern M, Katus HA, Frey N (2010) Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovasc Res 86:452–460CrossRefPubMed

36.

Shou W, Aghdasi B, Armstrong DL, Guo Q, Bao S, Charng MJ, Mathews LM, Schneider MD, Hamilton SL, Matzuk MM (1998) Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 391:489–492CrossRefPubMed

37.

Lee Y, Song AJ, Baker R, Micales B, Conway SJ, Lyons GE (2000) Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res 86:932–938CrossRefPubMed

38.

Crawford SE, Qi C, Misra P, Stellmach V, Rao MS, Engel JD, Zhu Y, Reddy JK (2002) Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors. J Biol Chem 277:3585–3592CrossRefPubMed

39.

King T, Bland Y, Webb S, Barton S, Brown NA (2002) Expression of Peg1 (Mest) in the developing mouse heart: involvement in trabeculation. Dev Dyn 225:212–215CrossRefPubMed

40.

Shi W, Chen H, Sun J, Buckley S, Zhao J, Anderson KD, Williams RG, Warburton D (2003) TACE is required for fetal murine cardiac development and modeling. Dev Biol 261:371–380CrossRefPubMed

41.

Phillips HM, Rhee HJ, Murdoch JN, Hildreth V, Peat JD, Anderson RH, Copp AJ, Chaudhry B, Henderson DJ (2007) Disruption of planar cell polarity signaling results in congenital heart defects and cardiomyopathy attributable to early cardiomyocyte disorganization. Circ Res 101:137–145CrossRefPubMed

42.

Phillips HM, Murdoch JN, Chaudhry B, Copp AJ, Henderson DJ (2005) Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract. Circ Res 96:292–299CrossRefPubMed

43.

Nakamura T, Colbert M, Krenz M, Molkentin JD, Hahn HS, Dorn GW 2nd, Robbins J (2007) Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome. J Clin Invest 117:2123–2132CrossRefPubMedPubMedCentral

44.

DiMichele LA, Hakim ZS, Sayers RL, Rojas M, Schwartz RJ, Mack CP, Taylor JM (2009) Transient expression of FRNK reveals stage-specific requirement for focal adhesion kinase activity in cardiac growth. Circ Res 104:1201–1208CrossRefPubMedPubMedCentral

45.

Lee YC, Chang CJ, Bali D, Chen YT, Yan YT (2011) Glycogen-branching enzyme deficiency leads to abnormal cardiac development: novel insights into glycogen storage disease IV. Hum Mol Genet 20:455–465CrossRefPubMed

46.

Li D, Hallett MA, Zhu W, Rubart M, Liu Y, Yang Z, Chen H, Haneline LS, Chan RJ, Schwartz RJ, Field LJ, Atkinson SJ, Shou W (2011) Dishevelled-associated activator of morphogenesis 1 (Daam1) is required for heart morphogenesis. Development 138:303–315CrossRefPubMedPubMedCentral

47.

Kosaka Y, Cieslik KA, Li L, Lezin G, Maguire CT, Saijoh Y, Toyo-oka K, Gambello MJ, Vatta M, Wynshaw-Boris A, Baldini A, Yost HJ, Brunelli L (2012) 14-3-3epsilon plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. Mol Cell Biol 32:5089–5102CrossRefPubMedPubMedCentral

48.

Ashraf H, Pradhan L, Chang EI, Terada R, Ryan NJ, Briggs LE, Chowdhury R, Zarate MA, Sugi Y, Nam HJ, Benson DW, Anderson RH, Kasahara H (2014) A mouse model of human congenital heart disease: high incidence of diverse cardiac anomalies and ventricular noncompaction produced by heterozygous Nkx2-5 homeodomain missense mutation. Circ Cardiovasc Genet 7:423–433CrossRefPubMedPubMedCentral

49.

Inoue S, Moriya M, Watanabe Y, Miyagawa-Tomita S, Niihori T, Oba D, Ono M, Kure S, Ogura T, Matsubara Y, Aoki Y (2014) New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome. Hum Mol Genet 23:6553–6566CrossRefPubMed

50.

Liu Z, Li W, Ma X, Ding N, Spallotta F, Southon E, Tessarollo L, Gaetano C, Mukouyama YS, Thiele CJ (2014) Essential role of the zinc finger transcription factor Casz1 for mammalian cardiac morphogenesis and development. J Biol Chem 289:29801–29816CrossRefPubMedPubMedCentral

51.

Kokoszka JE, Waymire KG, Flierl A, Sweeney KM, Angelin A, MacGregor GR, Wallace DC (2016) Deficiency in the mouse mitochondrial adenine nucleotide translocator isoform 2 gene is associated with cardiac noncompaction. Biochim Biophys Acta 1857:1203–1212CrossRefPubMedPubMedCentral

52.

Clay H, Wilsbacher LD, Wilson SJ, Duong DN, McDonald M, Lam I, Park KE, Chun J, Coughlin SR (2016) Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development. Dev Biol 418:157–165CrossRefPubMedPubMedCentral

53.

Hirai M, Arita Y, McGlade CJ, Lee KF, Chen J, Evans SM (2017) Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. J Clin Invest 127:569–582CrossRefPubMedPubMedCentral

54.

Bourke LM, Del Monte-Nieto G, Outhwaite JE, Bharti V, Pollock PM, Simmons DG, Adam A, Hur SS, Maghzal GJ, Whitelaw E, Stocker R, Suter CM, Harvey RP, Harten SK (2017) Loss of rearranged L-Myc fusion (RLF) results in defects in heart development in the mouse. Differentiation 94:8–20CrossRefPubMed

55.

Baardman ME, Zwier MV, Wisse LJ, Gittenberger-de Groot AC, Kerstjens-Frederikse WS, Hofstra RM, Jurdzinski A, Hierck BP, Jongbloed MR, Berger RM, Plosch T, DeRuiter MC (2016) Common arterial trunk and ventricular non-compaction in Lrp2 knockout mice indicate a crucial role of LRP2 in cardiac development. Dis Model Mech 9:413–425CrossRefPubMedPubMedCentral

56.

Lin W, Li D, Cheng L, Li L, Liu F, Hand NJ, Epstein JA, Rader DJ (2018) Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. J Clin Invest 128:826–833CrossRefPubMedPubMedCentral

57.

Cao Q, Shen Y, Liu X, Yu X, Yuan P, Wan R, Liu X, Peng X, He W, Pu J, Hong K (2017) Phenotype and functional analyses in a transgenic mouse model of left ventricular noncompaction caused by a DTNA mutation. Int Heart J 58:939–947CrossRefPubMed

58.

Chen X, Qin L, Liu Z, Liao L, Martin JF, Xu J (2015) Knockout of SRC-1 and SRC-3 in mice decreases cardiomyocyte proliferation and causes a noncompaction cardiomyopathy phenotype. Int J Biol Sci 11:1056–1072CrossRefPubMedPubMedCentral

59.

Wang Y, Nathans J (2007) Tissue/planar cell polarity in vertebrates: new insights and new questions. Development 134:647–658CrossRefPubMed

60.

Simons M, Mlodzik M (2008) Planar cell polarity signaling: from fly development to human disease. Annu Rev Genet 42:517–540CrossRefPubMedPubMedCentral

61.

Hirschy A, Schatzmann F, Ehler E, Perriard JC (2006) Establishment of cardiac cytoarchitecture in the developing mouse heart. Dev Biol 289:430–441CrossRefPubMed

62.

Henderson DJ, Chaudhry B (2011) Getting to the heart of planar cell polarity signaling. Birth Defects Res A 91:460–467CrossRef

Title: Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC)
Authors: Ying Liu
Hanying Chen
Weinian Shou
Publication date: 01-08-2018
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 6/2018
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-018-1882-z

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC)

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2018

Prognostic Value of Serum Apelin Level in Children with Heart Failure Secondary to Congenital Heart Disease

Patient Characteristics and Emergency Department Factors Associated with Survival After Sudden Cardiac Arrest in Children and Young Adults: A Cross-Sectional Analysis of a Nationally Representative Sample, 2006–2013

Digoxin Use in Infants with Single Ventricle Physiology: Secondary Analysis of the Pediatric Heart Network Infant Single Ventricle Trial Public Use Dataset

The Genetic Landscape of Hypoplastic Left Heart Syndrome

Pediatric Pulmonary Artery Rehabilitation: A Review of Our Experience and a Novel Approach Using Bronchial Blockers

Impact of Flow Differentials According to Cardiac and Respiratory Cycles on Three Types of Fontan Operation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page